跳至主要内容
临床试验/ACTRN12618000098235
ACTRN12618000098235已完成1 期

A single dose, randomized, blinded, bioequivalence study of a test formulation of mesalazine tablet in a 3 way crossover comparison against the innovator mesalazine tablet conducted under fed conditions in healthy male and female volunteers

Zenith Technology Corp Ltd0 个研究点目标入组 36 人开始时间: 2018年1月23日最近更新:

试验速览

阶段
1 期
状态
已完成
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 55 Years(—)
性别
All

入选标准

  • Healthy male and non-pregnant females
  • Aged between 18 and 55
  • Non-smoker
  • BMI between 18 and 33 inclusive
  • Normal, healthy individuals as determined by medical history, physical examination, ECG, blood pressure and laboratory tests
  • Able to provide written informed consent

排除标准

  • Any history of recent recurrent attacks of bronchitis, asthma, migraine headaches
  • Concomitant drug therapy of any kind
  • Sensitivity to the study drug
  • History of any conditions that might interfere with the absorption, distribution, metabolism or excretion of the drug
  • Females who are pregnant and/or are breastfeeding
  • Smoker (anyone who has smoked in the last 6 months)
  • History of alcohol or drug abuse or dependency
  • Participation in a drug study within 60 days of the start of the study or donated blood in the 60 days preceding the study.
  • Volunteers for whom the Clinical Investigator believes, for any reason, that participation would not be an acceptable risk

研究者

相似试验

已完成
1 期
Comparative assessment of the absorption of a generic formulation of ibuprofen sustained release tablet against the innovator ibuprofen sustained release tablet conducted under fasting conditions in healthy male and female volunteersBioequivalence study conducted in healthy volunteers comparing two formulations of Ibuprofen with no health condition or problem studied. Although this study is being conducted in healthy volunteers who are not being treated for the condition to which the medicine is used, ibuprofen belongs to a class of medicines called an analgesic and anti-inflammatory. It is used for the treatment of rheumatoid arthritis, ankylosing spondylitis, osteoarthritis and other non-rheumatoid arthropathiesBioequivalence study conducted in healthy volunteers comparing two formulations of Ibuprofen with no health condition or problem studied.Although this study is being conducted in healthy volunteers who are not being treated for the condition to which the medicine is used, ibuprofen belongs to a class of medicines called an analgesic and anti-inflammatory. It is used for the treatment of rheumatoid arthritis, ankylosing spondylitis, osteoarthritis and other non-rheumatoid arthropathiesOther - Research that is not of generic health relevance and not applicable to specific health categories listed above
ACTRN12614001097639Zenith Technology Corp Ltd24
已完成
1 期
Comparative assessment of the absorption of a generic formulation of desvenlafaxine extended release tablet against the innovator desvenlafaxine extended release tablet conducted under fed conditions in healthy male and female volunteersBioequivalence study conducted in healthy volunteers comparing two formulations of desvenlafaxine with no health condition or problem studied. Although this study is being conducted in healthy volunteers who are not being treated for the condition to which the medicine is used, desvenlafaxine belongs to a class of medicines called Serotonin-Nonadrenaline Reuptake Inhibitors and is an antidepressant prescribed for the treatment and prevention of relapse of depression.Bioequivalence study conducted in healthy volunteers comparing two formulations of desvenlafaxine with no health condition or problem studied.Although this study is being conducted in healthy volunteers who are not being treated for the condition to which the medicine is used, desvenlafaxine belongs to a class of medicines called Serotonin-Nonadrenaline Reuptake Inhibitors and is an antidepressant prescribed for the treatment and prevention of relapse of depression.Other - Research that is not of generic health relevance and not applicable to specific health categories listed above
ACTRN12613000588796Zenith Technology Corporation Limited26
已完成
1 期
Comparative assessment of the absorption of a generic formulation of dofetilide capsule against the innovator dofetilide capsule conducted under fasting condition in healthy male and female volunteers.Atrial fibrillation
ACTRN12617000776303Zenith Technology Corporation Limited21
已完成
1 期
Comparative assessment of the absorption of a generic formulation of aspirin/dipyridamole extended release capsule against the innovator aspirin/dipyridamole extended release capsule conducted under fed conditions in healthy male and female volunteers
ACTRN12614000275662Zenith Technology Corporation Limited40
已完成
1 期
Comparative assessment of the absorption of a generic formulation of clonidine tablet against the innovator clonidine tablet conducted under fasting conditions in healthy male and female volunteers
ACTRN12615000280505Zenith Technology Corp Ltd24